Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) and AnaptysBio, Inc. (Anaptys) (Nasdaq: ANAB) today announced an exclusive, ...

LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the formation of its Strategic Advisory Board and the appointment of its ...

The very first moments of the Nintendo Switch 2 announcement trailer reveal that the new console is bigger than its predecessor. As the old Joy-Con unhook themselves from the original Switch ...

Following yesterday’s reports about Nintendo’s reveal plan for the Switch 2, a number of games were alleged to be set for the unannounced next-gen console. Leaker Nate the Hate, who was first ...

Company prepares to advance to Phase 2 clinical trial in early 2025HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), an ...

Previously dubbed Orphan, the series is inspired by the true story of Natalia Grace and the Midwestern couple who adopted her believing she was a little girl with dwarfism but gradually started to ...

Alnylam’s (ALNY) treatment of transthyretin-mediated amyloidosis, or ATTR amyloidosis, was granted FDA orphan designation, according to a post to the agency’s website. Published first on ...

Little Orphan Annie has been a staple of pop culture for almost 100 years, and the beloved redhead has appeared in comic ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on new products for rare diseases, today announced positive top-line results from ...

“My mother, father, and brothers are all buried in one grave,” she said. Alma Ja'arour is not like most children her age. Instead of talking about school and friends, her days are filled with ...

However, “orphan drugs” provide hope by offering treatment ... for pharma companies to develop drugs to treat rare diseases. 2 Whilst a rare disease is defined as affecting under 200,000 ...

Worried your lack of tap dancing skills is keeping you from living your best triple-threat life? Get back to the basics and ...